Peritoneovenous shunt for chylous ascites after lung transplantation for lymphangioleiomyomatosis

Transplant Proc. 2012 Jun;44(5):1390-3. doi: 10.1016/j.transproceed.2012.01.130.

Abstract

A 37-year-old woman with lymphangioleiomyomatosis (LAM) who underwent right single-lung transplantation from a cadaveric donor developed persistent chylous ascites. Despite use of diuretics and sirolimus to reduce ascites-associated symptoms and to prevent gastroesophageal reflex triggered by increased abdominal pressure, the ascites were refractory, and periodic paracenteses were required. With placement of a peritoneovenous shunt (Denver shunt), the patient's abdominal circumference decreased, and her symptoms abated. Thus, placement of a peritoneovenous shunt can be an effective management strategy for refractory chylous ascites in patients with LAM, even after lung transplantation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Chylous Ascites / diagnostic imaging
  • Chylous Ascites / etiology
  • Chylous Ascites / surgery*
  • Diuretics / therapeutic use
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lung Transplantation / adverse effects*
  • Lymphangioleiomyomatosis / surgery*
  • Paracentesis
  • Peritoneovenous Shunt*
  • Sirolimus / therapeutic use
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Diuretics
  • Immunosuppressive Agents
  • Sirolimus